Plant Variation in Tissue Culture: Understanding Somaclonal Variation and True-to-Type Control
- นภสร ตาปะสี
- 2 days ago
- 7 min read
Plant tissue culture makes it possible to multiply large numbers of plants from only a few selected mother plants within a relatively short period. However, the process is not a completely error-free form of biological copying.
A small proportion of regenerated plants may develop characteristics that differ from the mother plant, such as abnormal dwarfing, changes in leaf color, altered leaf shape, excessive shoot production, or reduced yield. These changes are known as somaclonal variation.
It is important to understand that tissue culture does not normally transform one plant species or cultivar into an entirely different one. For example, a tissue-cultured ‘Hom Thong’ banana will not become a Namwa banana. It remains the same cultivar, although some plants within the production population may develop off-type characteristics.
Somaclonal Variation Can Occur at Several Biological Levels
Somaclonal variation may result from several types of biological change, including:
Alterations in DNA sequences
Insertions or deletions of genetic material
Changes in chromosome structure
Changes in chromosome number
Shifts in ploidy level
Epigenetic modifications
Epigenetic changes affect how genes are switched on or off without necessarily changing the underlying DNA sequence.
For example, an increase in chromosome number may produce plants with thicker leaves, shorter growth, or slower development. Changes in DNA methylation may influence flowering, fruit set, growth habit, or leaf coloration, even when molecular-marker analysis does not detect differences at the selected DNA regions being tested.
This is why a plant can appear or perform differently despite showing a highly similar genetic profile under a limited marker system.
Not Every Abnormal-Looking Plant Is a Permanent Mutant
A plant that looks unusual after deflasking is not necessarily a permanent genetic variant.
Tissue-cultured plantlets often have thin leaves, soft stems, weak roots, or juvenile leaf shapes because they developed under high humidity, low light, limited gas exchange, and a culture medium containing sugar and plant growth regulators.
These characteristics may disappear after acclimatization. Once the plant begins producing new roots and leaves under greenhouse conditions, it may gradually develop the normal appearance of the cultivar.
For example, a newly deflasked Philodendron may initially produce small, simple leaves without the mature lobes or divisions expected from the cultivar. As the plant becomes older and receives suitable light, nutrition, and growing conditions, later leaves may develop the correct mature form.
Temporary physiological responses must therefore be distinguished from stable genetic or epigenetic changes.
The Regeneration Pathway Strongly Affects Risk
The method used to regenerate new plants has a major influence on the risk of somaclonal variation.
Direct multiplication from axillary buds, shoot tips, or existing meristematic tissues usually carries a lower risk because the shoots develop from organized tissues already present in the mother plant.
By contrast, regeneration through callus, cell suspension cultures, or somatic embryogenesis requires cells to dedifferentiate, divide repeatedly, and then reorganize into complete plants. These additional stages increase the opportunity for abnormalities to arise and accumulate.
For example, a variegated ornamental propagated from an axillary bud is generally more likely to retain its original pattern than a plant regenerated from a leaf-derived callus. Callus-based regeneration may produce fully green plants, albino plants, or plants with variegation patterns that differ from the mother stock.
When true-to-type production is the main objective, direct shoot proliferation is usually the lower-risk pathway.
Subculture Number and Hormone Exposure Matter
The number of subculture cycles and the concentration of plant growth regulators also influence variation risk.
As a culture line is multiplied through repeated generations, its cells undergo increasing numbers of divisions. This creates more opportunities for abnormal cells to arise and, in some cases, to be unintentionally selected during routine production.
High or prolonged exposure to BA, BAP, TDZ, or 2,4-D may rapidly increase shoot or callus production, but it may also contribute to:
Short, compact shoots
Hyperhydricity
Poor rooting
Excessive callus
Abnormal morphology
Increased off-type frequency
For example, a medium that produces 20 shoots per explant may initially appear superior to one producing only 10 shoots. However, if half of those 20 shoots are malformed, hyperhydric, or unable to root, the lower-multiplication formula may ultimately be more suitable for commercial production.
The most useful measure is therefore the number of healthy, normal, rootable, and marketable plants—not the highest theoretical shoot count.
The Mantled Oil Palm Case
One of the most important examples of tissue culture-related variation is the mantled abnormality in oil palm produced through somatic embryogenesis.
Affected palms develop abnormal flowers and fruits, resulting in severe yield loss. Research later showed that this condition was associated with altered DNA methylation around a retrotransposon known as Karma, rather than a direct change in the underlying DNA sequence.
This case demonstrates that economically serious abnormalities can arise through epigenetic mechanisms and may not be detected by conventional DNA-sequence comparisons alone.
It also illustrates why commercial quality control must extend beyond early laboratory stages. A plant may appear normal in vitro and during nursery production while still developing major reproductive abnormalities only after reaching maturity.
Off-Types in Banana Production
Banana provides another important commercial example.
In ‘Grand Nain’, researchers and producers have reported off-types such as dwarf plants, giant plants, and abnormal foliage. Some differences are not obvious while the plants remain inside culture vessels. They may only become clearly visible around eight to ten weeks after acclimatization or later in the field.
Other abnormalities, including delayed flowering, unusual bunch structure, or altered fruit characteristics, may not appear until the crop reaches the reproductive stage.
For this reason, laboratory inspection alone is not sufficient for traits that are expressed only in mature plants. Nursery screening and field evaluation remain essential parts of true-to-type quality control.
Variegated Plants and Chimeras Require Special Caution
Variegated plants are particularly vulnerable to pattern instability because many are chimeras.
A chimeral plant contains genetically different cell populations arranged in separate layers or sectors of the shoot meristem. During tissue culture, shoots may regenerate from only part of this cellular arrangement.
If one cell type becomes dominant, the regenerated plants may become:
Completely green
Almost entirely white
Less variegated
Differently patterned from the mother plant
Too weak to survive because of insufficient chlorophyll
For example, a bud located entirely within a green stem sector may produce a fully green shoot. A bud arising from a mostly white sector may produce a weak plant with too little chlorophyll to survive after deflasking.
Commercial producers should therefore avoid guaranteeing that every variegated plant will display exactly the same pattern as the mother plant unless cultivar-specific pilot trials have demonstrated a reliable acceptance rate.
True-to-Type Testing Requires Several Methods
No single testing method can fully confirm that every tissue-cultured plant is identical to the mother plant.
A comprehensive true-to-type assessment may combine:
Visual and morphological evaluation
Leaf color and pattern comparison
Plant height and growth habit
Shoot and sucker production
Flower and fruit characteristics
Field-performance assessment
Flow cytometry for ploidy screening
Chromosome analysis
Molecular markers such as RAPD, ISSR, SSR, or SCoT
Each method provides only part of the answer.
Molecular markers examine selected regions of the genome. If no difference is detected, the scientifically accurate conclusion is that no difference was found at the tested loci in the samples examined. It does not prove that every cell in every plant is identical across the entire genome.
Sampling design also matters. If only 10 plants are tested from a batch of 50,000 and no abnormality is detected, that result is not sufficient to prove that the entire batch contains no off-types—particularly when the true abnormality rate may be below 1%.
Quality claims should always reflect the sampling method, sample size, test coverage, and biological limitations of the assay.
How Commercial Laboratories Reduce the Risk
Commercial laboratories can reduce somaclonal variation through a structured production and quality-management system.
Key practices include:
Verifying mother plant identity and health
Using shoot tips, axillary buds, or organized meristems where possible
Avoiding unnecessary callus formation
Using the lowest effective hormone concentration
Limiting the duration of callus or cell cultures
Setting maximum subculture or passage numbers
Separating Master Cultures from Working Cultures
Maintaining traceability to the original mother plant
Recording medium formulas and subculture history
Removing abnormal cultures during multiplication
Screening plants during acclimatization
Conducting field trials for mature traits
Using molecular or ploidy testing where appropriate
Each production batch should be traceable to the mother plant, culture medium, number of passages, operator, rooting batch, acclimatization lot, and final inspection result.
This traceability makes it possible to identify which source plant, protocol, or culture generation is associated with an increased off-type rate.
Commercial Claims Should Be Scientifically Defensible
A claim that every tissue-cultured plant is “100% identical to the mother plant” goes beyond what current scientific evidence can support.
A more accurate statement would be:
“The sampled plants showed no detectable differences from the mother plant under the specified testing methods and conditions.”
For routine commercial communication, another appropriate statement is:
“The plants are produced under controlled propagation and quality-management systems designed to maintain a high degree of uniformity and true-to-type characteristics.”
These statements acknowledge the high level of consistency that tissue culture can achieve without suggesting that biological variation has been eliminated completely.
True-to-Type Production Is About Risk Control
Somaclonal variation does not mean that tissue culture is unreliable. Most plants produced through well-managed direct micropropagation remain highly uniform and close to the selected mother plant.
The key point is that tissue culture is a biological production system, not a perfect digital copying process.
Risk can be reduced substantially through the correct regeneration pathway, controlled hormone use, limited subculture cycles, clean Master Cultures, careful traceability, and quality assessment at the laboratory, nursery, and field stages.
The goal of commercial production is therefore not to claim that variation is impossible. It is to keep variation at the lowest practical level, detect abnormal plants as early as possible, and ensure that the final delivered batch meets the agreed commercial standard.
✨ channel for ordering ✨
Facebook Fanpage : ไทยทิชชู – ต้นไม้เพาะเนื้อเยื่อ ( Inbox 📩)
TikTok Shop : https://www.tiktok.com/@thaitissueshop
Shopee : https://shopee.co.th/thaitissue
🌱Other Contacts🌱
☎️ : 06-4475-7495 , 08-8629-4513
Line OA : https://lin.ee/UQFnpoN
Website : https://www.thaitissues.com/
Comments